Ishiyama T - Search Results

1

New highly active taxoids from 9beta-dihydrobaccatin-9,10-acetals. Part 3.

Takeda Y, Yoshino T, Uoto K, Chiba J, Ishiyama T, Iwahana M, Jimbo T, Tanaka N, Terasawa H, Soga T. Takeda Y, et al. Among authors: ishiyama t. Bioorg Med Chem Lett. 2003 Jan 20;13(2):185-90. doi: 10.1016/s0960-894x(02)00891-0. Bioorg Med Chem Lett. 2003. PMID: 12482420

2

New highly active taxoids from 9 beta-dihydrobaccatin-9,10-acetals.

Ishiyama T, Iimura S, Ohsuki S, Uoto K, Terasawa H, Soga T. Ishiyama T, et al. Bioorg Med Chem Lett. 2002 Apr 8;12(7):1083-6. doi: 10.1016/s0960-894x(02)00069-0. Bioorg Med Chem Lett. 2002. PMID: 11909723

3

New highly active taxoids from 9beta-dihydrobaccatin-9,10-acetals. Part 2.

Ishiyama T, Iimura S, Yoshino T, Chiba J, Uoto K, Terasawa H, Soga T. Ishiyama T, et al. Bioorg Med Chem Lett. 2002 Oct 21;12(20):2815-9. doi: 10.1016/s0960-894x(02)00628-5. Bioorg Med Chem Lett. 2002. PMID: 12270153

4

Synthesis and structure-activity relationships of novel 2',2'-difluoro analogues of docetaxel.

Uoto K, Ohsuki S, Takenoshita H, Ishiyama T, Iimura S, Hirota Y, Mitsui I, Terasawa H, Soga T. Uoto K, et al. Among authors: ishiyama t. Chem Pharm Bull (Tokyo). 1997 Nov;45(11):1793-804. doi: 10.1248/cpb.45.1793. Chem Pharm Bull (Tokyo). 1997. PMID: 9396156

5

A new method to modify the C-4 position of 10-deacetylbaccatin III.

Uoto K, Takenoshita H, Ishiyama T, Terasawa H, Soga T. Uoto K, et al. Among authors: ishiyama t. Chem Pharm Bull (Tokyo). 1997 Dec;45(12):2093-5. doi: 10.1248/cpb.45.2093. Chem Pharm Bull (Tokyo). 1997. PMID: 9433780

6

Discovery of DS42450411 as a potent orally active hepcidin production inhibitor: Design and optimization of novel 4-aminopyrimidine derivatives.

Fukuda T, Ishiyama T, Katagiri T, Ueda K, Muramatsu S, Hashimoto M, Aki A, Baba D, Watanabe K, Tanaka N. Fukuda T, et al. Among authors: ishiyama t. Bioorg Med Chem Lett. 2018 Nov 1;28(20):3333-3337. doi: 10.1016/j.bmcl.2018.09.010. Epub 2018 Sep 8. Bioorg Med Chem Lett. 2018. PMID: 30217414

7

Synthesis and SAR studies of 3,6-disubstituted indazole derivatives as potent hepcidin production inhibitors.

Fukuda T, Ueda K, Ishiyama T, Goto R, Muramatsu S, Hashimoto M, Watanabe K, Tanaka N. Fukuda T, et al. Among authors: ishiyama t. Bioorg Med Chem Lett. 2017 May 15;27(10):2148-2152. doi: 10.1016/j.bmcl.2017.03.056. Epub 2017 Mar 23. Bioorg Med Chem Lett. 2017. PMID: 28377056

8

Discovery of novel histone lysine methyltransferase G9a/GLP (EHMT2/1) inhibitors: Design, synthesis, and structure-activity relationships of 2,4-diamino-6-methylpyrimidines.

Katayama K, Ishii K, Tsuda E, Yotsumoto K, Hiramoto K, Suzuki M, Yasumatsu I, Igarashi W, Torihata M, Ishiyama T, Katagiri T. Katayama K, et al. Among authors: ishiyama t. Bioorg Med Chem Lett. 2020 Oct 15;30(20):127475. doi: 10.1016/j.bmcl.2020.127475. Epub 2020 Aug 8. Bioorg Med Chem Lett. 2020. PMID: 32781218

9

Discovery of DS79932728: A Potent, Orally Available G9a/GLP Inhibitor for Treating β-Thalassemia and Sickle Cell Disease.

Katayama K, Ishii K, Terashima H, Tsuda E, Suzuki M, Yotsumoto K, Hiramoto K, Yasumatsu I, Torihata M, Ishiyama T, Muto T, Katagiri T. Katayama K, et al. Among authors: ishiyama t. ACS Med Chem Lett. 2020 Dec 28;12(1):121-128. doi: 10.1021/acsmedchemlett.0c00572. eCollection 2021 Jan 14. ACS Med Chem Lett. 2020. PMID: 33488973 Free PMC article.

10

Protein Modification at Tyrosine with Iminoxyl Radicals.

Maruyama K, Ishiyama T, Seki Y, Sakai K, Togo T, Oisaki K, Kanai M. Maruyama K, et al. Among authors: ishiyama t. J Am Chem Soc. 2021 Dec 1;143(47):19844-19855. doi: 10.1021/jacs.1c09066. Epub 2021 Nov 17. J Am Chem Soc. 2021. PMID: 34787412

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

453 results

Search Page

Filters